Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

6.70
Delayed Data
As of Jan 19
 0.00 / 0.00%
Today’s Change
2.25
Today|||52-Week Range
6.75
+22.94%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close6.70
Today’s open6.50
Day’s range6.37 - 6.70
Volume475,685
Average volume (3 months)700,162
Market cap$219.9M
Data as of 4:00pm ET, 01/19/2018

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+48.73%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd0.000.00%
MRTXMirati Therapeutics ...0.000.00%
--Verona Pharma PLC0.000.00%
REPHRecro Pharma Inc0.000.00%
Data as of 4:00pm ET, 01/19/2018

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts